Nimotuzumab
OSAG101-PCS07
Phase 3 small_molecule completed
Quick answer
Nimotuzumab for Pancreatic Cancer, Advanced or Metastatic is a Phase 3 program (small_molecule) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Praxis Precision Medicines
- Indication
- Pancreatic Cancer, Advanced or Metastatic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed